Skip to main content

Table 1 Correlation between the expression of miR-939 and therapy response in GC patients (N = 110)

From: RETRACTED ARTICLE: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway

  

miR-939 expression level

 

All cases

Low expression

High expression

P value

Therapy response

 CR + PR

57

15

42

 

 NC + PD

53

41

12

P < 0.001

  1. CR complete response, PR partial response, NC no change, PD progressive disease